Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Benzinga

Bitcoin's New 2026 Target Is $150,000, Bernstein Says

Bernstein on Monday said that Bitcoin’s (CRYPTO: BTC) institutional base is solid enough to support a higher long-term trajectory, setting a new 2026 target at $150,000.

Benzinga

JPMorgan's $1.5 Trillion Security Push Lifts Spotlight On Defense, Critical Minerals And Tech ETFs

JPMorgan Chase Co‘s (NYSE:JPM) decision to hire Todd Combs, long viewed as a key figure in Berkshire Hathaway Inc’s (NYSE:BRK) succession bench, can spark fresh momentum in investment themes tied to U.S. national security and economic resilience.

Benzinga

Could The US Economy Enter A Recession While Hosting The 2026 World Cup?

In 2026, the United States, Canada and Mexico will jointly host the FIFA World Cup, the largest sporting event ever staged in North America, with 48 teams, expanded venues, and one of the most complex tourism and logistics operations in sports history.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

CoreWeave Joins Nebius, SMCI, IREN In Convertibles Frenzy — Bulls Beware

AI infrastructure might be the hottest trade on the screen, but the way it's being financed is a lot less glamorous.

Benzinga

Tesla Loses Key Bull Analyst: EV Giant Downgraded, While Rival GM Catches An Upgrade

Tesla Inc (NASDAQ:TSLA) shareholders may not love hearing that the electric vehicle stock has lost one of its top analysts. Morgan Stanley has assigned a new analyst to cover the stock, and he comes in hot with a downgrade on the stock.

Benzinga

Rocket Lab Shares Rally: What Investors Need To Know

Rocket Lab Corp (NASDAQ:RKLB) shares are trading higher Monday afternoon, continuing a rally that has seen the stock climb significantly over the past week. Investor sentiment remains resilient despite a minor schedule adjustment to the company’s upcoming RAISE and Shine mission. Here’s what investors need to know.

Benzinga

Tesla Stock Hits The Brakes: What's Driving Monday's Sell-Off?

Tesla Inc (NASDAQ:TSLA) shares slipped on Monday following Morgan Stanley’s downgrade of the stock from Overweight to Equal-Weight.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Solana Leads In Adoption, But ADA's 5% Spike Steals The Show

Solana (CRYPTO: SOL) continues to dominate real blockchain usage, but Cardano's (CRYPTO: ADA) 5% bounce has briefly redirected trader attention away from a chart that still shows structural weakness.

Benzinga

Nvidia, SoftBank Target 'Robot Brain' Maker In Potential $14 Billion Deal

SoftBank Group Corp.(OTC:SFTBF) (OTC:SFTBY) and NVIDIA Corp (NASDAQ:NVDA) are in talks to back a major new funding round for a fast-growing robotics artificial intelligence company, highlighting rising investor interest in the sector.

Benzinga

'Cash Is Still King': Paramount CEO David Ellison Throws $108 Billion All-Cash Bid To WBD Shareholders

In a move that upended the media landscape, Paramount Skydance Corp. (NASDAQ:PSKY) officially launched a hostile, all-cash tender offer for Warner Bros. Discovery, Inc. (NASDAQ:WBD) on Monday.

Benzinga

Dyne's Duchenne Drug Shows Strong Muscle And Function Improvements

Dyne Therapeutics, Inc. (NASDAQ:DYN) on Monday revealed topline results from the Registrational Expansion Cohort (REC) of its Phase 1/2 DELIVER trial evaluating zeleciment rostudirsen (z-rostudirsen, also known as DYNE-251) for Duchenne muscular dystrophy (DMD) amenable to exon 51 skipping.

Benzinga

What's Up With The Pullback In Apple Stock Today?

Apple Inc (NASDAQ:AAPL) shares are trading marginally lower on Monday. Despite the dip, a notable analyst has raised the price target on the stock.

Benzinga

Paramount Skydance Rallies On Hostile Bid, Netflix Tumbles: What's Moving Markets Monday?

U.S. stocks kicked off the week in a mixed pattern, with sentiment turning cautious as traders consider a Fed rate cut all but fully baked into current valuations. CME FedWatch tool currently assigns a 90% likelihood to a quarter-point reduction at the Dec. 10 meeting.

Benzinga

'Rich Dad, Poor Dad' Robert Kiyosaki Says $100 Used To Buy Groceries For 8 Months, Now It Barely Buys Lunch —'Stop Thinking Like An OG Loser'

Robert Kiyosaki, best-selling author of "Rich Dad, Poor Dad," built a financial empire around one idea: the wealthy don't save money — they buy assets. While some see his market crash predictions as overblown, others hang on his every word, believing he sees the writing on the wall long before…

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Wave Life Sciences One-Shot Obesity Drug Slashes Dangerous Visceral Fat

Wave Life Sciences Ltd. (NASDAQ:WVE) on Monday shared interim data from the lowest therapeutic cohort of the ongoing first-in-human INLIGHT trial evaluating WVE-007, an investigational INHBE GalNAc-siRNA using Wave’s proprietary SpiNA design, for obesity.

Benzinga

Why Is Arcellx Stock Surging Today?

Arcellx Inc. (NASDAQ:ACLX) shared new data on Saturday from its pivotal Phase 2 iMMagine-1 study of anitocabtagene autoleucel (anito-cel) for relapsed or refractory multiple myeloma (RRMM).

Benzinga

Air Products Stock Drops As Talks With Yara Continue

Air Products and Chemicals Inc. (NYSE:APD) and Yara International ASA (OTC:YARIY) are collaborating to connect low-emission ammonia supplies from projects in Louisiana and Saudi Arabia to Yara's global distribution network, with the aim of making key commercial decisions in 2026.

Benzinga

Fulcrum Therapeutics Stock Rally Ignited By Promising Sickle Cell Results

Fulcrum Therapeutics Inc. (NASDAQ:FULC) stock is surging on Monday, after the company released initial results from the ongoing 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

This Math Genius & Blackjack Pioneer Met Warren Buffett In Late 1960s, 'This is Going To Be The Richest Man in the World' — Here's Why He Knew

American mathematics professor, blackjack pioneer and hedge fund manager Edward Thorp says he recognized Warren Buffett's potential to become the richest man in the world when he first met the Oracle of Omaha in the late 1960s.

Benzinga

Marvell Technology Stock Slides To Start The Week: What's Happening?

Marvell Technology, Inc. (NASDAQ:MRVL) shares are trading lower Monday after Benchmark downgraded the stock from a Buy rating to a Hold rating.

Benzinga

Ocular Therapeutix Stock Skyrockets On Faster FDA Path For Vision Drug

Ocular Therapeutix Inc. (NASDAQ:OCUL) stock surged on Monday after the company announced plans to accelerate the timeline for submitting a New Drug Application (NDA) for Axpaxli (OTX-TKI) in the treatment of wet age-related macular degeneration (wet AMD).

Benzinga

4 Generous Stocks Set to Beat the Market

The investment world loves to complicate simple truths. Wall Street will sell you exotic strategies, complex derivatives, and algorithmic trading systems that require three PhD mathematicians to understand.

Benzinga

Germany's Bankruptcy Wave Sends Shock Ripples Through Two Key Equity ETFs

Germany is on course for the highest corporate insolvency count in more than a decade, raising fresh questions about the resilience of the nation’s largest listed companies — and the ETFs that track them.

Benzinga

Crude Oil Falls Over 1%; Structure Therapeutics Shares Jump

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 200 points on Monday.

Benzinga

Lululemon Runs Into Tariff Trouble While Racing To Refresh Core Collections

Lululemon Athletica Inc. (NASDAQ:LULU) heads into its third-quarter report with slowing sales growth, a sharp margin squeeze from tariffs and weaker U.S. demand, as investors watch whether a major product “newness” push can reignite momentum, but likely not before 2026.

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.